Search

Your search keyword '"Mulot C"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Mulot C" Remove constraint Author: "Mulot C"
139 results on '"Mulot C"'

Search Results

1. UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?

3. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

4. 321P A comprehensive predicting model of recurrence in stage III colon cancer from PETACC-8 trial

6. 562P Acquired genomic alterations on first-line chemotherapy (CT) + cetuximab in advanced colorectal cancer (mCRC): Circulating tumor (ct)DNA analysis of the randomized phase II trial TIME-PRODIGE-28

7. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.

9. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

10. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

11. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

12. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

13. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

14. Genome-wide association study of germline variants and breast cancer-specific mortality

15. Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)

16. Genome-wide association study of germline variants and breast cancer-specific mortality

17. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

18. Genome-wide association study of germline variants and breast cancer-specific mortality.

19. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

20. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

21. Genome-wide association study of germline variants and breast cancer-specific mortality

22. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

23. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

24. Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration

25. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

26. miR-31 as a prognostic and predictive marker of disease-free survival (DFS) in resected stage III colon cancer: A retrospective analysis of the PETACC-8 trial

28. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

29. Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy

30. A "chamber of errors" adaptation to assess pharmaceutical assistants' knowledge in chemotherapy preparation.

32. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

33. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

34. MicroRNA related polymorphisms and breast cancer risk

35. Adjuvant FOLFOX+ cetuximab vs FOLFOX in full RAS and BRAF wild type stage III colon cancer patients: Results from the PETACC8 trial

36. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

37. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

38. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

40. MicroRNA related polymorphisms and breast cancer risk

41. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

42. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

43. MicroRNA Related Polymorphisms and Breast Cancer Risk

44. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

45. MicroRNA Related Polymorphisms and Breast Cancer Risk

47. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: Evidence from the Breast Cancer Association Consortium

48. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

49. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

Catalog

Books, media, physical & digital resources